Wavefront-Guided Photorefractive Keratectomy in the Treatment of High Astigmatism Following Keratoplasty.


Journal

Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186

Informations de publication

Date de publication:
Mar 2019
Historique:
pubmed: 18 12 2018
medline: 16 2 2019
entrez: 18 12 2018
Statut: ppublish

Résumé

To report the outcome of wavefront-guided photorefractive keratectomy (WG-PRK) in the treatment of high astigmatism following keratoplasty. A retrospective, interventional analysis including patients with high astigmatism following either penetrating keratoplasty or deep anterior lamellar keratoplasty, who underwent WG-PRK. Thirteen eyes (7 right eyes) of 12 patients (10 male) aged 35.1 ± 5.9 years were included. Preoperative astigmatism ranged between 3.00 and 5.00 D. Average follow-up time was 14.0 ± 6.2 months. Uncorrected distance visual acuity (UDVA) improved from 0.97 ± 0.58 logarithm of the minimum angle of resolution (logMAR) (Snellen equivalent ∼20/187) preoperatively to 0.13 ± 0.15 logMAR (Snellen equivalent ∼20/27) at 6 months and 0.14 ± 0.16 logMAR (Snellen equivalent ∼20/28) at the final follow-up (P = 0.001 and P = 0.002, respectively). UDVA ≥20/40 increased from 1 eye (7.7%) preoperatively to 13 eyes (100%) at 6 months and 12 eyes (92.3%) at the final follow-up (P < 0.001 for both). UDVA ≥20/25 increased from 1 eye (7.7%) preoperatively to 6 eyes (46.2%) at 6 months and at the final follow-up (P = 0.027 for both). Mean astigmatism improved from -3.98 ± 0.75 D to -1.27 ± 0.82 D and -1.40 ± 1.04 at 6 months and at the last follow-up, respectively (P = 0.001 for both). Preoperative astigmatism was ≥3.00 D in all eyes and was reduced to ≤2.50 D in all eyes at 6 months postoperatively, with 7 eyes (63.6%) having ≤1.00 D of astigmatism at both 6 months and the final follow-up. WG-PRK was safe and effective in the treatment of high and regular postkeratoplasty astigmatism.

Identifiants

pubmed: 30557231
doi: 10.1097/ICO.0000000000001830
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

285-289

Auteurs

Nir Sorkin (N)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada.

Mohammad Kreimei (M)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada.

Adi Einan-Lifshitz (A)

Ophthalmology Department, Assaf Harofeh Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Zale Mednick (Z)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada.

Avner Belkin (A)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada.

Clara C Chan (CC)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada.

Allan R Slomovic (AR)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada.

David S Rootman (DS)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH